Turn Therapeutics released an updated corporate presentation on July 28, 2026. The filing was submitted to the SEC and included forward-looking statem...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
CTS Corp reiterates its standard cautionary attachment regarding forward-looking statements. This document outlines potential risks and factors that c...
PACCAR reported strong second-quarter 2026 results with net sales of $7.55 billion and net income of $752 million, driven by elevated demand for heavy...
Hubbell Inc. reported Q2 2026 diluted EPS of $4.52 and raised its FY 2026 adjusted diluted EPS outlook to $20.25-$20.55, driven by strong demand in ut...
Mid Penn Bancorp submitted an Investor Presentation to the SEC detailing recent developments, as well as forward-looking financial statements and busi...
Ecolab delivered accelerated organic sales growth and double-digit adjusted EPS in Q2, raising its 2026 adjusted EPS outlook to $8.05-$8.25....
The Nasdaq Hearings Panel has approved a continued listing for Edible Garden, subject to maintaining a minimum closing bid price of $1.00 per share th...
Kidz AI Inc. authorized a 50% increase to its existing share repurchase program, raising the authorized value to $3.0 million to enhance shareholder v...
SunPower posted a $12.5 million non-GAAP operating loss and saw quarterly revenue decline to $56 million. The company reaffirmed Q3 2026 operating inc...
Commvault reported record subscription revenue and free cash flow for Q1 FY'27, with guidance raised for the full year. The company also inked a strat...
InfuSystem announced it will report second quarter 2026 financial results and host an investor conference call on August 4, 2026....
XPLR Infrastructure reported strong second-quarter net income and adjusted EBITDA, while completing a $150 million buyout and fully repaying its $500 ...
Kiniksa reported Q2 revenue driven by ARCALYST and advanced KPL-387 into Phase 3, raising fiscal expectations....
Boeing generated $24.6 billion in Q2 revenue driven by higher deliveries, despite GAAP and core operating losses. The company reported record total ba...
Grace Therapeutics announced the FDA did not identify safety or efficacy deficiencies after a Type A meeting, clearing clinical pathways for GTx-104. ...
Repligen reported 13% organic Q2 2026 revenue growth and raised its FY26 guidance, while announcing a definitive agreement to acquire BioLife Solution...
S&P Global reported Q2 2026 revenue and earnings growth despite a pending Mobility division spin-off. Post-spin leadership emphasized operational focu...
Xylem Inc. reported second-quarter revenue of $2.3 billion and adjusted EPS of $1.46. The company raised its 2026 revenue outlook, citing strengthened...
Core Scientific reported Q2 2026 revenue of $164.2 million and Net loss of $1.16 billion, primarily due to warrant revaluation, while announcing a str...
Sherwin-Williams reported a 7.5% increase in consolidated net sales, which exceeded guidance and pushed adjusted diluted earnings per share estimates ...